69.0
Tempest Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
33.0
FY23:
40.4
FY24:
31.5
FY25:
8.27
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.28
FY22:
13.1
FY23:
11.2
FY24:
10.0
FY25:
8.66
Total assets
Change from FY21 to FY25
millions USD
FY21:
73.2
FY22:
46.1
FY23:
51.6
FY24:
41.5
FY25:
16.9
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
20.0
FY22:
7.28
FY23:
9.41
FY24:
14.2
FY25:
3.31
(negative)
Change from FY21 to FY25
millions USD
FY21:
17.1
FY22:
20.7
FY23:
15.4
FY24:
8.14
FY25:
6.95
(positive)
Change from FY21 to FY25
millions USD
FY21:
36.1
FY22:
18.1
FY23:
26.8
FY24:
19.1
FY25:
6.67
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
73.2
FY22:
46.1
FY23:
51.6
FY24:
41.5
FY25:
16.9
All amounts in millions USD